DSDebra A. Schaumberg

Debra A. Schaumberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Debra A. Schaumberg has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    C-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts

    by Vinod P. Mitta, William G. Christen, Robert J. Glynn, Richard D. Semba, Paul M. Ridker, Eric B. Rimm, Susan E. Hankinson, Debra A. Schaumberg

    Inflammation plays a significant role in the incidence and progression of age-related macular degeneration (AMD),1-3 the leading cause of blindness among older adults in the United States.4 Drusen, subretinal deposits indicative of the onset of AMD, have been shown to contain fibrinogen, vitronectin, complement components, and C-reactive protein (CRP), proteins associated with generalized inflammation.5-7 Inflammatory cell debris has also been isolated from the outer surface of the Bruch membrane in eyes with AMD.8 The inflammatory hypothesis has been further strengthened by the discovery of a strong association between AMD and a common gene variant for complement factor H,9-12 as well as variants in other complement pathway genes.13-15


  • Top Cited Papers

    Dry Eye Disease: Impact on Quality of Life and Vision

    by Miki Uchino, Debra A. Schaumberg

    Dry eye disease (DED) is a growing public health concern causing ocular discomfort, fatigue, and visual disturbance that interferes with quality of life (QoL), including aspects of physical, social, and psychological functioning, daily activities, and workplace productivity. This article assesses the current understanding of the impact of DED on QoL and vision. The full impact of DED on a patient’s QoL is not easily quantifiable, but several methods and techniques have been evaluated to measure the decreased quality of vision from DED, and a number of questionnaires have been developed to quantify the impact of DED on various aspects of patient QoL. We summarize available evidence on the impact of DED from a review of published literature.


  • Open Access

    Prospective Study of Common Variants in the Retinoic Acid Receptor–Related Orphan Receptor α Gene and Risk of Neovascular Age-Related Macular Degeneration

    by Debra A. Schaumberg, Daniel Chasman, Margaux A. Morrison, Scott M. Adams, Qun Guo, David J. Hunter, Susan E. Hankinson, Margaret M. DeAngelis

    The leading cause of blindness in white persons in the United States and other industrialized countries,1 age-related macular degeneration (AMD) has emerged as a paradigmatic example of a common complex disease caused by the interplay of genetic predisposition and exposure to modifiable risk factors.2 A large number of studies have established relationships between lifestyle factors such as diet, cigarette smoking, and obesity as well as common variants within a handful of genes and risk of AMD in multiple populations. Among the genetic risk factors, common variants in 2 genes, complement factor H (CFH) (1q32) and ARMS2/HTRA serine peptidase 1 (HTRA1) (10q26), have strong and consistent associations with risk of AMD and are estimated to contribute to a strikingly large proportion of AMD cases in the US population.2 Nonetheless, not every individual with a risk factor or set of risk factors will develop AMD, and efforts at developing risk prediction models based on currently understood risk factors are insufficient to reliably predict the development and progression of AMD in individuals.3 Refinements in exposure assessment for epidemiological risk factors such as cigarette smoking, diet, and obesity, as well as the identification of other disease-associated variants, may improve the predictive ability and lead to clinically relevant interventions to identify individuals that require closer follow-up and earlier or more targeted forms of intervention.


  • Top Cited Papers
    Open Access

    Prevalence of Dry Eye Disease Among US Men

    by Debra A. Schaumberg, Reza Dana, Julie E. Buring, David A. Sullivan

    Dry eye is one of the most prevalent eye diseases and reasons for seeking eye care among older people. It is an important public health problem, causing increased risk of ocular infections and bothersome symptoms of ocular discomfort, fatigue, and visual disturbance that interfere with crucial activities such as reading, working on a computer, and driving a car.1-3 Studies over the past decade have identified older age, female sex, reduced androgen levels, exogenous estrogen use, and an imbalance in the dietary intake of essential fatty acids as important risk factors for dry eye disease (DED).1,4-6A large-scale study of participants in the Women's Health Study estimated that 3.25 million US women 50 years and older are affected with clinically important DED.6The present study examined the prevalence and risk factors for DED among 25 444 middle-aged and older men participating in the Physicians' Health Studies I and/or II (PHS I and PHS II).


  • Open Access

    Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial

    by Julie Lin, Robert J. Glynn, Nader Rifai, JoAnn E. Manson, Paul M. Ridker, David M. Nathan, Debra A. Schaumberg

    OBJECTIVE—Progressive nephropathy represents a substantial source of morbidity and mortality in type 1 diabetes. Increasing albuminuria is a strong predictor of progressive renal dysfunction and heightened cardiovascular risk. Early albuminuria probably reflects vascular endothelial dysfunction, which may be mediated in part by chronic inflammation. RESEARCH DESIGN AND METHODS—We measured baseline levels of four inflammatory biomarkers (high-sensitivity C-reactive protein, soluble intercellular adhesion molecule-1 [sICAM-1], soluble vascular cell adhesion molecule-1, and soluble tumor necrosis factor-α receptor-1) in stored blood samples from the 1,441 participants of the Diabetes Control and Complication Trial (DCCT). We used mixed-effects regression models to determine the average annual change in urinary albumin excretion rate (AER) by tertiles of each biomarker. We also used Cox proportional hazards models to estimate the relative risk of incident sustained microalbuminuria according to levels of each biomarker. RESULTS—After adjustment for baseline age, sex, duration of diabetes, A1C, and randomized treatment assignment, we observed a significantly higher 5.9 μg · min−1 · year−1 increase in AER among those in the highest compared with the lowest tertile of baseline sICAM-1 (P = 0.04). Those in the highest tertile of sICAM-1 had an adjusted relative risk of 1.67 (95% CI 0.96–2.92) of developing incident sustained microalbuminuria (Ptrend = 0.03). CONCLUSIONS—Higher baseline sICAM-1 levels predicted an increased risk of progressive nephropathy in type 1 diabetes and may represent an early risk marker that reflects the important role of vascular endothelial dysfunction in this long-term complication.


  • Open Access

    High-Sensitivity C-Reactive Protein, Other Markers of Inflammation, and the Incidence of Macular Degeneration in Women

    by Debra A. Schaumberg, William G. Christen, Julie E. Buring, Robert J. Glynn, Nader Rifai, Paul M. Ridker

    Recent evidence suggests that inflammation and abnormalities of innate immunity play a role in the pathogenesis of age-related macular degeneration (AMD),1 the leading cause of blindness among older adults.2 A strong association between a common variant of the gene for complement factor H (CFH) and AMD has recently imparted considerable weight to this hypothesis.3-9 These data coincide with the view that low-grade inflammation plays a more general role in the aging process itself,10 as well as in other age-related disorders.11 Patterns of AMD progression12,13 viewed in the context of the development of an increasingly proinflammatory status with age10 suggest the possibility that this disease may develop via at least 2 somewhat discrete steps. The first involves the accumulation of extracellular debris beneath the retina at varying rates among individuals, which may plausibly be relatedto up-regulation of immunoinflammatory responses and the development of AMD.14 The second step, which occurs in only a subset, leads to neovascular lesions and/or geographic atrophy. In the case of neovascular AMD, this process involves an overt inflammatory/neovascular response originating from the choroidal vasculature.12,15


  • Top Cited Papers

    Impact of Dry Eye Syndrome on Vision-Related Quality of Life

    by Biljana Miljanović, Reza Dana, David A. Sullivan, Debra A. Schaumberg


  • Development and Validation of a Short Global Dry Eye Symptom Index

    by Debra A. Schaumberg, Abha Gulati, William D. Mathers, Thomas Clinch, Michael A. Lemp, J. Daniel Nelson, Gary N. Foulks, Reza Dana


  • Open Access

    A Prospective Study of 2 Major Age-Related Macular Degeneration Susceptibility Alleles and Interactions With Modifiable Risk Factors

    by Debra A. Schaumberg, Susan E. Hankinson, Qun Guo, Eric Rimm, David J. Hunter

    Age-related macular degeneration (AMD) is a potentially blinding disease with lifestyle and genetic risk factors.1 A common single nucleotide polymorphism in the gene for complement factor H (CFH) (rs1061170; sequence, T1277C; protein, Y402H) is strongly associated with AMD,2-12 and its consistency and plausible biological reasoning suggest that the relationship is causal. Linkage analyses also identified a second major gene for AMD on chromosome 10q, with the strongest evidence for a coding single nucleotide polymorphism in the predicted gene LOC387715.7,10 Although the evidence of association of these variants with AMD is strong, the magnitude of prior estimates must be considered in light of the study design and the selected nature of cases and controls. In most instances, the cases were prevalent and had features of advanced AMD,2-10 and the controls in some studies were restricted to individuals who had no family history of AMD,4,6 both of which instances might bias risk estimates upward.13


  • Open Access

    A Prospective Assessment of the Y402H Variant in Complement Factor H, Genetic Variants in C-Reactive Protein, and Risk of Age-Related Macular Degeneration

    by Debra A. Schaumberg, William G. Christen, Piotr Kozlowski, David T. Miller, Paul M. Ridker, Robert Y. L. Zee

    Purpose. Two biologically related factors, complement factor H (CFH) and C-reactive protein (CRP), have been associated with AMD. The Y402H variant of CFH is located within the binding site of CFH for CRP. Although plasma CRP levels have been related to AMD and plasma CRP levels are partly determined by genetic variation, there is no information on whether genetic variants in CRP are associated with AMD. methods. A prospective analysis was performed of 111 men who eventually developed AMD and 401 men who remained free of AMD, all participants in the Physicians’ Health Study. Genotypes were determined for the common T→C single nucleotide polymorphism (SNP) in exon 9 of CFH (rs1061170; protein Y402H), as well as seven previously described CRP SNPs (rs3093059, rs2794521, rs3091244, rs1417938, rs1800947, rs1130864, and rs1205). Logistic regression analysis was used to evaluate individual SNPs, as well as six CRP haplotypes for association with AMD. results. The high-risk C allele of CFH was present in 45% of cases and 34% of controls. An odds ratio (OR) of 1.46 was observed for AMD (95% confidence interval [CI]: 1.05–2.04) for TC heterozygotes and an OR of 2.13 (95% CI: 1.10–4.16) for CC homozygotes, assuming a multiplicative (log-additive) model and attributable fraction of 25% (95% CI: 1% to 44%) was calculated. For CRP, single-marker or haplotype-based analysis failed to reveal any significant associations with a risk of AMD. conclusions. These prospective data confirmed an association between the Y402H variant of CFH and a risk of AMD. In contrast, although a biologically plausible, genetic variation in CRP does not appear to be associated with a risk of AMD. Further prospective studies of a larger number of subjects are needed to substantiate available information on the genetic epidemiology of AMD.